Thornton & Ross Ltd

STADA Thornton & Ross is focused on a three-pillar strategy consisting of consumer healthcare products, generics, and specialty pharmaceuticals.

Caring for customers since 1922, we’re now proud to support Britain’s wellbeing in multiple settings, including consumer healthcare, hospital, primary care, pharmacy and homecare.

We’re proud of our continued UK success. Year-on-year growth has been consistent, and 2023 sales totalled £219 million, with a 14% increase in turnover and 34% growth in net profit.

Our company is part of the STADA Group - STADA Arzneimittel AG | STADA - a leading global manufacturer of high-quality pharmaceuticals. As of December 2023, STADA employed 11,466 people worldwide.